Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | -69.19%661.47B | -69.19%661.47B | 182.88%792.83B | 107.42%465.17B | 1,188.22%1.07T | 885.05%2.15T | 885.05%2.15T | 532.80%280.27B | 373.41%224.27B | 130.58%82.68B |
-Cash and cash equivalents | 30.89%652.98B | 30.89%652.98B | 669.76%772.51B | 301.34%248.54B | 301.33%231.31B | 231.01%498.89B | 231.01%498.89B | 189.05%100.36B | 53.83%61.93B | 95.83%57.64B |
-Money market investments | -99.48%8.49B | -99.48%8.49B | -88.71%20.32B | 33.44%216.64B | 3,229.09%833.82B | 2,351.82%1.65T | 2,351.82%1.65T | 1,779.76%179.91B | 2,180.98%162.35B | 289.73%25.05B |
Receivables | 45.46%404.41B | 45.46%404.41B | 35.18%336.49B | 110.08%321.01B | 15.58%150.76B | 81.50%278.02B | 81.50%278.02B | 142.24%248.92B | 61.41%152.81B | 134.12%130.44B |
-Accounts receivable | -83.27%9.09B | -83.27%9.09B | -75.91%19.92B | -6.18%43.87B | -83.18%6.85B | --54.37B | --54.37B | 209.30%82.68B | 86.13%46.76B | 659.84%40.75B |
-Notes receivable | 98.91%306.59B | 98.91%306.59B | 76.32%254.02B | 169.96%242.56B | 53.35%115.5B | 42.97%154.13B | 42.97%154.13B | 121.44%144.07B | 49.87%89.85B | 78.60%75.32B |
-Other receivables | 27.64%88.73B | 27.64%88.73B | 182.19%62.56B | 113.54%34.59B | 97.66%28.4B | 53.23%69.52B | 53.23%69.52B | 102.19%22.17B | 68.74%16.2B | 75.69%14.37B |
Prepaid assets | -25.69%9.63B | -25.69%9.63B | 254.46%12.64B | 416.85%13.33B | 383.67%11.7B | 212.00%12.95B | 212.00%12.95B | 151.88%3.56B | 85.60%2.58B | 103.23%2.42B |
Net loan | 109.30%1.79T | 109.30%1.79T | 687.86%1.29T | 571.34%965.45B | 375.75%624.31B | 47.37%856.24B | 47.37%856.24B | 52.03%163.65B | 38.31%143.81B | 16.36%131.23B |
-Gross loan | 105.93%1.84T | 105.93%1.84T | 653.72%1.33T | 540.59%995.86B | 348.66%647.26B | 44.45%894.24B | 44.45%894.24B | 48.11%176.19B | 38.86%155.46B | 27.92%144.26B |
-Allowance for loans and lease losses | 29.94%49.37B | 29.94%49.37B | 208.35%38.68B | 160.99%30.41B | 76.00%22.94B | -0.17%38B | -0.17%38B | 10.87%12.55B | 45.92%11.65B | --13.04B |
Securities and investments | 61.32%1.08T | 61.32%1.08T | 137.31%1.03T | 1,964.71%1.19T | 29.00%395.09B | -28.34%671.12B | -28.34%671.12B | 88.08%432.04B | -75.34%57.86B | 62.66%306.26B |
-Available for sale securities | 61.39%1.08T | 61.39%1.08T | 137.31%1.03T | 1,964.71%1.19T | 29.00%395.09B | -28.41%670.43B | -28.41%670.43B | 88.08%432.04B | -75.34%57.86B | 62.66%306.26B |
-Short term investments | -4.59%658.37M | -4.59%658.37M | ---- | ---- | ---- | --690.07M | --690.07M | ---- | ---- | ---- |
Long term equity investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --448.93M | ---- |
Derivative assets | -44.00%4.63B | -44.00%4.63B | -36.80%1.76B | 229.96%4.23B | 695.77%4.98B | 797.93%8.26B | 797.93%8.26B | 1,047.30%2.78B | 294.71%1.28B | 299.58%625.77M |
Net PPE | -8.49%101.94B | -8.49%101.94B | 193.85%100.42B | 243.99%90.33B | 244.68%76.43B | 94.68%111.39B | 94.68%111.39B | 99.35%34.17B | 83.17%26.26B | 79.84%22.18B |
-Gross PPE | -0.78%257.33B | -0.78%257.33B | 193.85%100.42B | 243.99%90.33B | 244.68%76.43B | 105.27%259.34B | 105.27%259.34B | 99.35%34.17B | -10.62%26.26B | -10.87%22.18B |
-Accumulated depreciation | -5.03%-155.39B | -5.03%-155.39B | ---- | ---- | ---- | -114.04%-147.95B | -114.04%-147.95B | ---- | ---- | ---- |
Goodwill and other intangible assets | 12.72%166.01B | 12.72%166.01B | 217.13%142.99B | 265.48%121.93B | 279.78%100.76B | 112.32%147.28B | 112.32%147.28B | 134.92%45.09B | 116.34%33.36B | 104.14%26.53B |
-Goodwill | 0.00%58.86B | 0.00%58.86B | 169.16%54.48B | 223.63%48.59B | 237.87%40.98B | 89.69%58.86B | 89.69%58.86B | 121.83%20.24B | 100.70%15.01B | 90.19%12.13B |
-Other intangible assets | 21.18%107.16B | 21.18%107.16B | 256.20%88.51B | 299.73%73.34B | 315.08%59.78B | 130.63%88.43B | 130.63%88.43B | 146.77%24.85B | 131.08%18.35B | 117.57%14.4B |
Defined pension benefit | -35.54%769.15M | -35.54%769.15M | ---- | ---- | ---- | 207.62%1.19B | 207.62%1.19B | --432.09M | --182.08M | --143.44M |
Other assets | 21.28%267.11B | 21.28%267.11B | 353.09%294.22B | -56.77%161.87B | 222.40%141.72B | 105.21%220.25B | 105.21%220.25B | 95.29%64.94B | 1,409.89%374.43B | 93.47%43.96B |
Total assets | 0.54%4.51T | 0.54%4.51T | 209.49%4T | 223.23%3.34T | 237.94%2.57T | 106.91%4.48T | 106.91%4.48T | 129.51%1.29T | 90.27%1.03T | 70.56%761.08B |
Liabilities | ||||||||||
Total deposits | -5.32%3.15T | -5.32%3.15T | 186.29%2.73T | 160.83%2.07T | 203.87%1.73T | 98.27%3.33T | 98.27%3.33T | 125.52%954.2B | 88.45%793.28B | 66.87%569.51B |
Federal funds purchased and securities sold under agreement to repurchase | 1,558.57%33.96B | 1,558.57%33.96B | 15,650.54%115.44B | ---- | ---- | --2.05B | --2.05B | -68.42%732.93M | --877.62M | ---- |
Payables | -37.09%101.38B | -37.09%101.38B | 85.69%118.57B | 894.44%393.26B | 147.46%108.66B | 104.14%161.15B | 104.14%161.15B | 166.23%63.86B | 66.94%39.55B | 218.70%43.91B |
-Accounts payable | -46.63%62.26B | -46.63%62.26B | 69.18%85.02B | 1,148.35%367.09B | 360.07%81.31B | 105.15%116.66B | 105.15%116.66B | 177.31%50.26B | 58.72%29.41B | 85.39%17.67B |
-Total tax payable | -12.02%39.12B | -12.02%39.12B | 146.81%33.55B | 158.21%26.16B | 197.55%27.35B | 101.50%44.46B | 101.50%44.46B | 131.98%13.6B | 96.56%10.13B | 116.86%9.19B |
-Other payable | -99.42%152K | -99.42%152K | -98.60%92K | -99.33%48K | -99.94%10.69M | 129.45%26.3M | 129.45%26.3M | 114.72%6.59M | 10.44%7.13M | 214,997.51%17.05B |
Current accrued expenses | 65.20%116.01B | 65.20%116.01B | 168.39%58.62B | 202.34%48.86B | 241.68%38.95B | 99.24%70.23B | 99.24%70.23B | 128.30%21.84B | 121.51%16.16B | 90.37%11.4B |
Current debt and capital lease obligation | 15.53%4.64B | 15.53%4.64B | ---- | ---- | ---- | 34.26%4.02B | 34.26%4.02B | ---- | ---- | ---- |
-Current capital lease obligation | 15.53%4.64B | 15.53%4.64B | ---- | ---- | ---- | 34.26%4.02B | 34.26%4.02B | ---- | ---- | ---- |
Trading liabilities | --0 | --0 | 30,597.39%364.99M | -65.87%230.49M | 22.92%2.55B | -80.13%1.32B | -80.13%1.32B | -99.70%1.19M | -70.80%675.27M | -48.25%2.07B |
Long term provisions | 25.16%40.6B | 25.16%40.6B | 1,172.01%50.02B | 2,024.88%46.08B | 1,689.82%39.07B | 515.83%32.44B | 515.83%32.44B | 187.89%3.93B | 105.93%2.17B | 115.97%2.18B |
Long term debt and capital lease obligation | 2,286.75%52.65B | 2,286.75%52.65B | 1,262.73%28.14B | 137.10%4.81B | 16,744.08%3.81B | -39.41%2.21B | -39.41%2.21B | 8.11%2.07B | 3.51%2.03B | -98.59%22.61M |
-Long term debt | --51.16B | --51.16B | --22.36B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Long term capital lease obligation | -32.33%1.49B | -32.33%1.49B | 180.10%5.78B | 137.10%4.81B | 16,744.08%3.81B | 16.55%2.21B | 16.55%2.21B | 52.66%2.07B | 43.48%2.03B | -97.87%22.61M |
Non current deferred liabilities | -33.93%3.63B | -33.93%3.63B | 869.59%17.06B | 2,570.43%18.24B | 945.12%6.01B | 246.23%5.49B | 246.23%5.49B | 370.99%1.76B | 153.77%683.11M | 71.22%575.01M |
Derivative product liabilities | --1.73B | --1.73B | --55.25M | --28M | ---- | --0 | --0 | ---- | ---- | --625K |
Other liabilities | 54.56%200.66B | 54.56%200.66B | 283.50%139.8B | 251.60%110.11B | 349.86%81.72B | 99.32%129.82B | 99.32%129.82B | 94.90%36.45B | 90.64%31.32B | 8.56%18.16B |
Total liabilities | -0.82%3.71T | -0.82%3.71T | 200.49%3.26T | 203.44%2.69T | 210.46%2.01T | 98.97%3.74T | 98.97%3.74T | 125.19%1.08T | 87.09%886.74B | 68.38%647.84B |
Shareholders'equity | ||||||||||
Share capital | -1.12%437.73M | -1.12%437.73M | -1.12%437.73M | -1.03%438.12M | 0.00%442.67M | -0.39%442.67M | -0.39%442.67M | -2.16%442.67M | -3.08%442.67M | -3.08%442.67M |
-common stock | -1.12%437.73M | -1.12%437.73M | -1.12%437.73M | -1.03%438.12M | 0.00%442.67M | -0.39%442.67M | -0.39%442.67M | -2.16%442.67M | -3.08%442.67M | -3.08%442.67M |
Paid-in capital | 0.00%554.29B | 0.00%554.29B | 209.00%513.1B | 3,340.27%457.59B | 273.64%385.94B | 109.78%554.29B | 109.78%554.29B | 129.54%166.05B | -77.57%13.3B | 104.30%103.29B |
Retained earnings | -7.74%89.74B | -7.74%89.74B | 375.89%89.69B | 937.05%72.07B | 1,467.07%124.33B | 407.41%97.27B | 407.41%97.27B | 409.86%18.85B | 385.59%6.95B | -413.22%-9.09B |
Less: Treasury stock | 158.80%12.48B | 158.80%12.48B | 481.37%19.59B | 572.78%16.82B | 287.87%7.83B | 179.10%4.82B | 179.10%4.82B | 702.85%3.37B | --2.5B | --2.02B |
Gains losses not affecting retained earnings | 206.27%106.59B | 206.27%106.59B | 1,822.12%90.49B | 2,066.26%79.49B | 17.39%10.25B | 25.71%34.8B | 25.71%34.8B | -28.59%4.71B | -28.71%3.67B | 31.18%8.73B |
Other equity interest | -3.68%59.15B | -3.68%59.15B | 213.77%62.76B | -55.11%55.92B | 299.01%47.1B | 116.80%61.41B | 116.80%61.41B | 146.05%20B | 1,792.58%124.58B | 112.89%11.8B |
Total stockholders'equity | 7.31%797.74B | 7.31%797.74B | 256.53%736.89B | 342.96%648.69B | 395.10%560.22B | 158.74%743.4B | 158.74%743.4B | 155.12%206.68B | 112.06%146.44B | 84.15%113.15B |
Non controlling interests | 78.74%1.06B | 78.74%1.06B | 450.89%904.26M | 375.90%550.55M | 411.78%458.21M | 161.56%595.08M | 161.56%595.08M | 155.91%164.15M | 110.18%115.69M | 82.25%89.53M |
Total equity | 7.37%798.8B | 7.37%798.8B | 256.69%737.79B | 342.99%649.24B | 395.11%560.68B | 158.74%743.99B | 158.74%743.99B | 155.12%206.85B | 112.06%146.56B | 84.15%113.24B |
Currency Unit | ARS | ARS | ARS | ARS | ARS | ARS | ARS | ARS | ARS | ARS |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |